We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Extravasation Detector Wins Design Excellence Award

By HospiMedica staff writers
Posted on 16 Jun 2008
Medrad, Inc. (Warrendale, PA, USA), announced that its XDS extravasation detector has received a 2008 Medical Design Excellence Award (MDEA). The XDS employs a technology that aids in the detection of leaking intravenous contrast media from the injection site into surrounding tissue during computed tomography (CT) diagnostic studies.

"This prestigious award recognizes our XDS extravasation detector technology, the investment of many resources for research and development, and the inherent risk of developing medical devices; the MDEA validates that the investment and risk were worth it,” said Cliff Kress, senior vice president, Medrad CT Business Unit. "We are proud that we have succeeded in developing an extravasation technology that continues Medrad's long-standing commitment to patient safety.”

The MDEA competition, presented by Canon Communications (Los Angeles, CA, USA) and sponsored by Medical Device & Diagnostic Industry Magazine, recognizes medical product excellence in design and engineering features, innovative use of materials, user-related functions that improve healthcare delivery, features that benefit patients, and the ability of the development team to overcome challenges. An impartial, multi-disciplinary panel of jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics reviewed the entries and selected the winners.

Medrad and development partner, Battelle Medical Device Solutions (Columbus, OH, USA), will accept the award at a ceremony June 4, 2008, at the Medical Design & Manufacturing (MD&M) East 2008 Conference and Exposition in New York, NY, USA.

Medrad is a worldwide provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, Medrad's product range includes a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Medrad is an affiliate of Bayer AG (Leverkusen, Germany).


Related Links:
Medrad
Canon Communications
Half Apron
Demi
Ultrasound Table
Women’s Ultrasound EA Table
Biopsy Software
Affirm® Contrast
Ultrasound Needle Guidance System
SonoSite L25

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.